JoVE Logo
Faculty Resource Center

Sign In

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

DOI :

10.3791/54170-v

September 1st, 2016

September 1st, 2016

8,649 Views

1Neurotrauma Research, Swedish Medical Center, 2Neurosurgery, Colorado Brain and Spine Institute

Our studies have revealed that the beneficial effects of conivaptan are dependent on the method of delivery after experimental stroke in mice. We have developed a research protocol for delivery of the receptor blocker via IV catheter on stroke-evoked brain edema formation in mice.

Tags

Continuous IV Infusion

-- Views

Related Videos

article

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice

article

The Measurement and Treatment of Suppression in Amblyopia

article

Orthotopic Aortic Transplantation in Mice for the Study of Vascular Disease

article

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

article

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

article

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

article

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

article

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

article

Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function

article

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved